Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTate & Lyle Regulatory News (TATE)

Share Price Information for Tate & Lyle (TATE)

Share Price is delayed by 15 minutes
Get Live Data
504.50    -0.50 (-0.10%)
Bid:
504.00
Ask:
506.00
Spread: 2.00 (0.397%)
Market Cap: £2.23b
TATE Live PriceLast checked at - London Stock Exchange

Intraday Tate & Lyle Share Chart

Board Changes

30 Dec 2020 13:00

RNS Number : 1356K
Tate & Lyle PLC
30 December 2020
 

30 December 2020

 

Tate & Lyle PLC

 

 

BOARD CHANGES

 

Tate & Lyle PLC (the "Company") announces that John Cheung will join the Board as a non-executive director and a member of the Audit and Nominations Committees on 1 January 2021.

 

Currently an executive director of nutrition group China Feihe Limited, John brings a breadth of food and beverage experience with a deep understanding of markets in Asia, particularly in China. In a career spanning 30 years in the fields of nutrition, food and beverages, John has served as President for Wyeth Nutrition Global, having previously served as Nestlé Group's leader in China and earlier held senior roles with Coca-Cola and Procter & Gamble.

 

After nearly nine years on the Board, the Company also announces that non-executive director, Dr Ajai Puri, will retire on 31st March 2021.

 

Dr Gerry Murphy, Chairman of Tate & Lyle, said: "I am delighted that John has agreed to join the Board. His appointment recognises the importance of the Asia Pacific region to Tate & Lyle's growth and development. His substantial experience in the Chinese and broader Asian food and beverage industry will be of significant benefit to the Board.

 

I also thank Dr Puri for his nine years of dedicated service and significant contribution to the Board and, in particular, for his time as Chairman of our Research Advisory Group. Ajai's wisdom, technological insights and management experience have been exceptionally valuable as Tate & Lyle has evolved into a global, science-led food ingredient business."

 

There are no further disclosures to be made in connection with Mr Cheung's appointment pursuant to paragraph 9.6.13 of the Financial Conduct Authority's Listing Rules.

 

END

 

For more information contactNick Hasell, FTI Consulting (Media)Tel: Mobile: +44 (0) 7825 523 383

Christopher Marsh, VP, Investor Relationschris.marsh@tateandlyle.com / +44 (0) 7796 192 688

 

About Tate & Lyle: Tate & Lyle PLC is a leading global provider of food and beverage ingredients and solutions. Supported by our 160-year history of ingredient innovation, we partner with customers to provide consumers with healthier and tastier choices when they eat and drink. We are proud that millions of people around the world consume products containing our ingredients every day.

Through our expertise in sweetening, mouthfeel and fibre fortification, our Food & Beverage Solutions business develops solutions which reduce sugar, calories and fat, add fibre, and provide texture and stability in categories including beverages, dairy, bakery, soups, sauces and dressings. Our Primary Products business produces nutritive sweeteners, industrial starches used in paper and packaging, acidulants and products used for animal nutrition.

We have around 4,200 employees working in more than 60 locations across 30 countries. Tate & Lyle's purpose is Improving Lives for Generations and through our purpose we believe we can successfully grow our business and have a positive impact on society. We live our purpose in three ways, by supporting healthy living, building thriving communities and caring for our planet.

Tate & Lyle is listed on the London Stock Exchange under the symbol TATE.L. American Depositary Receipts trade under TATYY. In the year to 31 March 2020, Tate & Lyle sales totalled £2.9 billion. For more information, please visit http://www.tateandlyle.com or follow Tate & Lyle on Twitter or Linkedin.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAWPGQCPUPUUBU
Date   Source Headline
29th May 20185:54 pmBUSDirector/PDMR Shareholding
24th May 20187:00 amBUSFinal Results
1st May 20181:00 pmBUSTotal Voting Rights
18th Apr 201812:27 pmBUSDirector/PDMR Shareholding
17th Apr 20187:00 amBUSImran Nawaz Appointed Chief Financial Officer of Tate & Lyle PLC
13th Apr 20181:48 pmBUSDirector Declaration
5th Apr 20184:31 pmBUSDirector/PDMR Shareholding
4th Apr 20184:47 pmBUSDirector/PDMR Shareholding
3rd Apr 201812:27 pmBUSTotal Voting Rights
2nd Mar 201812:04 pmBUSDirector/PDMR Shareholding
15th Feb 20183:44 pmBUSDirector/PDMR Shareholding
14th Feb 20182:55 pmBUSDirector/PDMR Shareholding
13th Feb 20182:03 pmBUSDirector/PDMR Shareholding
8th Feb 20187:00 amBUSTrading Statement
1st Feb 20183:38 pmBUSTotal Voting Rights
18th Jan 20184:12 pmBUSHolding(s) in Company
16th Jan 20187:00 amBUSNick Hampton Appointed Chief Executive of Tate & Lyle PLC
2nd Jan 20189:34 amBUSBlock listing Interim Review
8th Dec 20172:39 pmBUSDirector Declaration
4th Dec 20171:40 pmBUSDirector/PDMR Shareholding
24th Nov 201712:54 pmBUSDirector/PDMR Shareholding
20th Nov 20173:21 pmBUSHolding(s) in Company
16th Nov 20171:17 pmBUSHolding(s) in Company
13th Nov 20171:08 pmBUSHolding(s) in Company
2nd Nov 20177:00 amBUSHalf-year Report
1st Nov 20175:00 pmBUSHolding(s) in Company
19th Sep 20174:16 pmBUSHolding(s) in Company
13th Sep 201710:00 amBUSDirector/PDMR Shareholding
1st Sep 201710:00 amBUSTotal Voting Rights
17th Aug 201711:38 amBUSDirector/PDMR Shareholding
9th Aug 20174:00 pmBUSDirectorate change
3rd Aug 201711:00 amBUSResult of the External Audit Tender
27th Jul 20172:37 pmBUSResult of AGM
27th Jul 20177:00 amBUSTrading Statement
3rd Jul 201712:35 pmBUSTotal Voting Rights
3rd Jul 201712:34 pmBUSBlock listing Interim Review
30th Jun 20173:36 pmBUSDirector/PDMR Shareholding
29th Jun 20173:37 pmBUSDirector/PDMR Shareholding
26th Jun 20173:40 pmBUSDirector/PDMR Shareholding
19th Jun 20174:21 pmBUSAnnual Financial Report
16th Jun 20174:20 pmBUSDirector/PDMR Shareholding
14th Jun 20174:31 pmBUSHolding(s) in Company
1st Jun 20173:40 pmBUSTotal Voting Rights
31st May 20173:11 pmBUSHolding(s) in Company
26th May 201711:40 amBUSHolding(s) in Company
25th May 20177:00 amBUSFinal Results
18th May 20172:40 pmBUSHolding(s) in Company
2nd May 201711:55 amBUSTotal Voting Rights
26th Apr 201710:52 amBUSHolding(s) in Company
11th Apr 20175:05 pmBUSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.